PillRx only · Injection, Powder, Lyophilized, For Solution · Intramuscular
Ertapenem Sodium
Brands: Ertapenem · Invanz · Ertapenem Sodium
8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
8 active makers
8 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$33.992
Latest avg · Jul 22, 2026
+27%
Since Dec 17, 2025
8
Active US suppliers
33%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
9.1K
Rx · 2026 Q1
32K
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it8 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Endo USA, Inc. | unknown | 2 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 2 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 2 | SUPPLYING |
| Fosun Pharma USA Inc | unknown | 2 | SUPPLYING |
| Qilu Antibiotics Pharmaceutical Co., Ltd. | unknown | 1 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
| Merck Sharp & Dohme LLC. | unknown | 1 | SUPPLYING |
| Gland Pharma Limited | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.